Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Ingo Kleiter

1-50 of 57 results

View this query on the Wikidata Query Service
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

scientific article published in 2012
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)

scientific article published on November 23, 2013
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome

scientific article
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.

scientific article published on 26 September 2016
Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease

scientific article published on September 15, 2010
Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma

scientific article published in March 2004
Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-CD20 Therapy

scientific article published on March 1, 2013
Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients

scientific article published on 19 April 2013
Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses

scientific article
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome

scientific article
Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder

scientific article published on July 1, 2015
Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease

scientific article published on 07 May 2012
Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis

scientific article published on December 25, 2012
Smad7 in T cells drives T helper 1 responses in multiple sclerosis and experimental autoimmune encephalomyelitis

scientific article published on 30 March 2010
Update on biomarkers in neuromyelitis optica

scientific article (publication date: August 2015)
Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder

scientific article
Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response

scientific article published on June 2017
Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions

Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders

scientific article
Serum anti-Müllerian hormone levels in reproductive-age women with relapsing–remitting multiple sclerosis

scientific article published on August 21, 2014
Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study

scientific article published on 25 January 2016
Novel role for SLPI in MOG-induced EAE revealed by spinal cord expression analysis

scientific article published on 26 May 2008
Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.

scientific article published on 3 November 2015
Visual evoked potentials in neuromyelitis optica and its spectrum disorders

scientific article published on 5 September 2013
Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate

scientific article
Bridging, switching or drug holidays - how to treat a patient who stops natalizumab?

scientific article published on 03 October 2013
Activation of TGF‐β‐induced non‐Smad signaling pathways during Th17 differentiation

scientific article published on March 31, 2015
Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75.

scientific article published on 10 May 2015
Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations

scientific article published on February 19, 2016
Influence of female sex and fertile age on neuromyelitis optica spectrum disorders

scientific article
Analysis of neurogenesis during experimental autoimmune encephalomyelitis reveals pitfalls of bioluminescence imaging

scientific article published on 17 March 2015
Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS.

scientific article
Autonomic involvement in tick-borne encephalitis (TBE): report of five cases.

scientific article published in June 2006
Prophylactic antiepileptic treatment reduces seizure frequency in natalizumab-associated progressive multifocal leukoencephalopathy

scientific article published on January 2014
Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy

scientific article
TGF-β inhibitor Smad7 regulates dendritic cell-induced autoimmunity.

scientific article
Early changes on electroencephalography in natalizumab-associated progressive multifocal leucoencephalopathy

scientific article
A lightning strike to the head causing a visual cortex defect with simple and complex visual hallucinations

scientific article
Muscle cramps and neuropathies in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease

scientific article
Adherence, satisfaction and functional health status among patients with multiple sclerosis using the BETACONNECT® autoinjector: a prospective observational cohort study

scientific article published on 6 September 2017
Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?

scientific article
Aquaporin 4 antibody positive central nervous system autoimmunity and multiple sclerosis are characterized by a distinct profile of antibodies to herpes viruses

scientific article published on 10 August 2010
Autonomic and peripheral nervous system function in acute tick-borne encephalitis

scientific article published on 5 May 2016
Is It Too Early to Predict the Failure of Natalizumab in NMO?—Reply

Amphiphysin-positive paraneoplastic myelitis and stiff-person syndrome

scientific article published on 28 September 2016
Enhanced OCT4 transcriptional activity substitutes for exogenous SOX2 in cellular reprogramming.

scientific article
Numeracy of multiple sclerosis patients: A comparison of patients from the PERCEPT study to a German probabilistic sample

scientific article published on 17 July 2017
Benefit-risk perception of natalizumab therapy in neurologists and a large cohort of multiple sclerosis patients

scientific article published on 7 March 2017
Relevance of endoglin, IL-1α, IL-1β and anti-ovarian antibodies in females with multiple sclerosis

scientific article published on January 28, 2016
Smad7 in intestinal CD4+ T cells determines autoimmunity in a spontaneous model of multiple sclerosis

scientific article published on 03 December 2019

Paulina is supported by:

About Paulina

Help